Fenofibrate differentially activates PPARα-mediated lipid metabolism in rat kidney and liver. [PDF]
Pannala VR +8 more
europepmc +1 more source
Tirzepatide-associated interstitial kidney injury. [PDF]
Eldib M +5 more
europepmc +1 more source
PPARα: Linking Cardiac Metabolism to Therapeutic Opportunities in Cardiovascular Diseases. [PDF]
Roes M, Libert C, Vandewalle J.
europepmc +1 more source
PPARα modulation of macrophage polarization and inflammatory signaling in mimic periodontitis. [PDF]
Arthur HU, Chen YY.
europepmc +1 more source
Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model. [PDF]
Guo W +8 more
europepmc +1 more source
Alternate-day alternating monotherapy (q48h) versus daily concomitant atorvastatin-fenofibrate in adults with type 2 diabetes and mixed dyslipidemia: a 12-week randomized non-inferiority trial. [PDF]
Shahramirad S +4 more
europepmc +1 more source
TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis. [PDF]
Flourou C +4 more
europepmc +1 more source
Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy. [PDF]
Clements JN, Mesawich J, Twisdale C.
europepmc +1 more source
Chiglitazar Activates PPAR-α/γ to Suppress Oxidative Stress and Angiogenesis in Corneal Neovascularization. [PDF]
Tao T +10 more
europepmc +1 more source
Looking Beyond Severe Hypertriglyceridemia when Diagnosing Adult-Onset Citrullinemia Type II. [PDF]
Truong TH +6 more
europepmc +1 more source

